RADXRadiopharm Theranostics Limited American Depositary Shares
2.440USD+6.55%Mkt Cap: 19.23M $P/E: —3d ago
Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical nee…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap19.23M $
Enterprise Value-9.30M $
Revenue (TTM)16.28M $
Gross Profit39.28K $
Net Income (TTM)-38.34M $
Revenue/Share2.100 USD
Last Price2.440 USD
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.00
PEG—
EV/EBITDA0.24
EV/Revenue-0.57
P/S1.11
P/B0.72
EPS (TTM)-3.75
EPS (Forward)-2.30
52W Range
2.23072% of range2.520
52W High2.520 USD
52W Low2.230 USD
Profitability
Gross Margin1.08%
Oper. Margin-423.75%
EBITDA Margin-240.69%
Profit Margin-1055.27%
ROE-85.60%
ROA-44.34%
Growth
Revenue Growth154.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-37.10M $
CapEx (TTM)—
FCF Margin-128.23%
FCF Yield-108.52%
Net Debt-34.52M $
Net Debt/EBITDA0.88
Balance Sheet
Debt/Equity—
Current Ratio3.01
Quick Ratio3.00
Book Value/Sh3.179 USD
Cash/Share2.922 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)17.38 USD
Upside (mean)+612.2%
Target Range12.73 USD – 30.71 USD
$12.73+612.2% to mean$30.71
# Analysts6
Ownership
Shares Out.7.88M
Float9.08M
Insiders0.00%
Institutions0.81%
Short Interest
Short Ratio0.6d
Short % Float1.18%
Short % Out.0.94%
Shares Short74.10K
Short (prev mo.)62.57K
Technical
SMA 503.786 (-35.6%)
SMA 2004.533 (-46.2%)
Beta0.77
S&P 52W Chg21.00%
Avg Vol (30d)68.85K
Avg Vol (10d)45.62K
Technical Indicators
RSI (14)27.6
MACD-0.3850
MACD Signal-0.3789
MACD Hist.-0.0061
BB Upper3.513 USD
BB Middle2.852 USD
BB Lower2.191 USD
BB Width46.35%
ATR (14)0.2738 USD
Vol Ratio (20d)0.31x